SEC Filings

424B5
AVEXIS, INC. filed this Form 424B5 on 01/16/2018
Entire Document
 

Table of Contents

          An increase of $10.0 million in gross proceeds from the issuance of shares of common stock offered by us would increase the number of shares of common stock to be issued by us in the offering by 85,106 shares, would increase the as adjusted net tangible book value per share, after giving effect to this offering, by $0.21, and would decrease the dilution to investors purchasing shares in this offering by approximately $0.21 per share, assuming that the assumed public offering price remains the same, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.

          A decrease of $10.0 million in gross proceeds from the issuance of shares of common stock offered by us would decrease the number of shares of common stock to be issued by us in the offering by 85,106 shares, would decrease the as adjusted net tangible book value per share, after giving effect to this offering, by $0.21, and increase the dilution to investors purchasing shares in this offering by approximately $0.21 per share, assuming that the assumed public offering price remains the same, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.

          The as adjusted information discussed above is illustrative only and will be adjusted based on the actual public offering price and other terms of this offering determined at pricing.

          The information above assumes that the underwriters do not exercise their option to purchase additional shares. If the underwriters exercise in full their option to purchase $60,000,000 of additional shares of our common stock at the assumed public offering price of $117.50 per share, the last reported sale price of our common stock on The NASDAQ Global Select Market on January 12, 2018, our net tangible book value on September 30, 2017, after giving effect to this offering, would have been approximately $835.9 million, or approximately $23.29 per share, representing an immediate dilution of $94.21 per share to new investors purchasing shares of common stock in this offering.

          The number of shares of our common stock to be outstanding immediately following this offering as shown above is based on 31,972,377 shares of our common stock outstanding as of September 30, 2017 and excludes:

    3,310,475 shares of common stock issuable upon exercise of outstanding stock options as of September 30, 2017, at a weighted-average exercise price of $38.04 per share;

    87,266 shares of common stock issuable upon the settlement of outstanding restricted stock units as of September 30, 2017;

    305,775 shares of common stock issuable upon the exercise of outstanding warrants as of September 30, 2017, at a weighted-average exercise price of $2.57 per share;

    105,237 shares issued for non-cash consideration after September 30, 2017 in a transaction not registered under the Securities Act; and

    up to a maximum of 2,049,712 shares of common stock reserved for future issuance under our 2016 Equity Incentive Plan, or the 2016 Plan, as of September 30, 2017, as well as any automatic increase in the number of shares of common stock reserved for future issuance under the 2016 Plan.

S-18



© AveXis, Inc. All Rights Reserved.